[Treatment of rosacea with metronidazole internally and externally].
Twenty-two patients suffering from rosacea papulosa or rosacea papulo-pustulosa were treated with Metronidazole at a low dosage (125 or 250 mg/d) for 2 to 6 months. According to our observations during a follow-up period of 12 months, this long-term therapy is well-tolerated and early recurrences are rare in comparison to the former short-term therapy with Metronidazole. It may be called an alternative to tetracycline therapy.
D000284:Administration, Oral; D000287:Administration, Topical; D000328:Adult; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use*; D008875:Middle Aged; D012008:Recurrence; D012393:Rosacea / Q000188:drug therapy*
D008795:Metronidazole
Zur Behandlung der Rosacea mit Metronidazol innerlich und äusserlich.